| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Herlev Hospital |
| Information provided by: | Herlev Hospital |
| ClinicalTrials.gov Identifier: | NCT00197899 |
Purpose
The purpuse of this study is to examine the acute phase respons when different doses of E. Coli Endotoxin is injected in healty volunters.
| Condition | Intervention |
|
Endotoxemia Sepsis |
Drug: E. Coli endotoxin |
| MedlinePlus related topics: | Sepsis |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Randomized, Double-Blind, Dose Comparison, Crossover Assignment |
Eligibility
| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: Healty volunteers -
Exclusion Criteria:
Infection 14 days prior to the trial Regular medication Present and /or former heart disease -
Contacts and Locations| Denmark, Copenhagen County | |||||
| Department of Intensive Care | |||||
| Copenhagen, Copenhagen County, Denmark, 2730 | |||||
| Herlev Hospital |
| Study Chair: | Bente K Pedersen, MD, DMSc | Department of Infectious Diseases 7641, University Hospital of Copenhagen, H:S Rigshospitalet |
| Principal Investigator: | Dorthe H Olsen, MD | Department of Intensive Care, Herlev University Hospital |
| Study Director: | Dorthe H Olsen, DM | Department of Intensive Care, Herlev University Hospital |
More Information
| Study ID Numbers: | KA 04015 |
| First Received: | September 13, 2005 |
| Last Updated: | December 12, 2005 |
| ClinicalTrials.gov Identifier: | NCT00197899 |
| Health Authority: | Denmark: The Regional Committee on Biomedical Research Ethics |
|
|
|
|
